Non-viral delivery

Non-viral delivery for gene therapy A next generation gene therapy delivery approach The Duchenne Research Fund committed £320,000 to accelerate research into alternative ways to deliver gene therapy to Duchenne patients, with the aim of increasing the number of...

CRISPR

CRISPR for Duchenne Genome editing technology to correct the mutated dystrophin gene The Duchenne Research Fund awarded a £200,000 grant to the team at the Hospital for Sick Children in Toronto, Canada (‘Sick Kids’), to work on using CRISPR/Cas9 technology...

GOSH coordinator

Great Ormond Street Hospital Clinical Trial Co-ordinator Manju Agarwal As part of the Newcastle Plan in 2015/16, eight patient organisations contributed £1.2m to fund at least 16 vital posts across the UK to support and expand clinical trial capacity for Duchenne...

Duchenne Care UK project manager

Treat-NMD Duchenne Muscular Dystrophy Programme Co-ordinator Cathy Turner The Duchenne Research fund together with Duchenne UK and Joining Jack jointly fund the senior project manager and project coordinator roles for Duchenne Care UK at the John Walton Muscular...

Ringo

Ringo Dystrophic dogs provide insights into Duchenne research The Duchenne Research Fund supported Professor Mayana Zatz, Natássia Vieira and their team at the University of Sao Paulo, Brazil, who investigated why two golden retrievers showed no severe symptoms...